Clinical and radiological outcomes of directed treatment transitions from Gilenya® to generic fingolimod.

Saved in:
Bibliographic Details
Title: Clinical and radiological outcomes of directed treatment transitions from Gilenya® to generic fingolimod.
Authors: Patel MA; College of Osteopathic Medicine, Kansas City University, Kansas City, MO, USA., Punnen TG; School of Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Shan KS; School of Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA., McCreary MC; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Wright CM; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Munoz SB; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Hardeman P; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Burgess KW; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Greenberg BM; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Horton LA; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Sguigna PV; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Tardo LM; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Stüve O; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Neurology Section, Dallas Veterans Affairs Medical Center, Dallas, TX, USA., Okuda DT; Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Feb; Vol. 32 (2), pp. 192-201. Date of Electronic Publication: 2026 Jan 03.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-0970
DOI:10.1177/13524585251401404